President Trump announced a deal with Eli Lilly and Novo Nordisk to lower prices on hugely popular weight-loss drugs for Medicare, Medicaid and American patients who pay with their own money.
ยฉ M. Scott Brauer for The New York Times
Americans have been able to buy Wegovy and Zepbound for about $500 a month in most cases.